메뉴 건너뛰기




Volumn 50, Issue 4, 1999, Pages 331-335

Effect of disopyramide on left ventricular pressure gradient in hypertrophic obstructive cardiomyopathy in comparison with propranolol - A case report

Author keywords

[No Author keywords available]

Indexed keywords

DISOPYRAMIDE; PROPRANOLOL;

EID: 0033006841     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905000410     Document Type: Article
Times cited : (7)

References (8)
  • 1
    • 0031984468 scopus 로고    scopus 로고
    • Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy
    • Sherrid MV, Pearle G, Gunsburg DZ: Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation 97:41-47, 1998.
    • (1998) Circulation , vol.97 , pp. 41-47
    • Sherrid, M.V.1    Pearle, G.2    Gunsburg, D.Z.3
  • 2
    • 0027318313 scopus 로고
    • Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy
    • Kimball BP, Bui S, Wigle ED: Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy. Am Heart J 125:1691-1697, 1993.
    • (1993) Am Heart J , vol.125 , pp. 1691-1697
    • Kimball, B.P.1    Bui, S.2    Wigle, E.D.3
  • 3
    • 0023812613 scopus 로고
    • Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration
    • Pollick C, Kimball B, Henderson M, et al: Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol 62:1248-1251, 1988.
    • (1988) Am J Cardiol , vol.62 , pp. 1248-1251
    • Pollick, C.1    Kimball, B.2    Henderson, M.3
  • 4
    • 0023756911 scopus 로고
    • Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration
    • Pollick C: Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration. Am J Cardiol 62:1252-1255, 1988.
    • (1988) Am J Cardiol , vol.62 , pp. 1252-1255
    • Pollick, C.1
  • 5
    • 0023699943 scopus 로고
    • Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy
    • Sherrid M, Delia E, Dwyer E: Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 62:1085-1088, 1988.
    • (1988) Am J Cardiol , vol.62 , pp. 1085-1088
    • Sherrid, M.1    Delia, E.2    Dwyer, E.3
  • 6
    • 0030870039 scopus 로고    scopus 로고
    • Class la antiarrhythmic drug cibenzoline. A new approach to the medical treatment of hypertrophic obstructive cardiomyopathy
    • Hamada M, Shigematsu Y, Ikeda S, et al: Class la antiarrhythmic drug cibenzoline. A new approach to the medical treatment of hypertrophic obstructive cardiomyopathy. Circulation 96:1520-1524, 1997.
    • (1997) Circulation , vol.96 , pp. 1520-1524
    • Hamada, M.1    Shigematsu, Y.2    Ikeda, S.3
  • 7
    • 0029148123 scopus 로고
    • Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy
    • Matsubara H, Nakatani S, Nagata S, et al: Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 26:768-775, 1995.
    • (1995) J Am Coll Cardiol , vol.26 , pp. 768-775
    • Matsubara, H.1    Nakatani, S.2    Nagata, S.3
  • 8
    • 0022296412 scopus 로고
    • Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echographic study
    • Bourmayan C, Razavi A, Fournier C, et al: Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echographic study. Am Heart J 109:1311-1316, 1985.
    • (1985) Am Heart J , vol.109 , pp. 1311-1316
    • Bourmayan, C.1    Razavi, A.2    Fournier, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.